• Citer

Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study

par Duck, Lionel;Demolin, Gauthier;D'Hondt, Lionel;Dopchie, Catherine;Hendrickx, Koen;Lannoye, Beatrice;Bastin, Fabienne;Lossignol, Dominique ;Hamdan, Ossama;Lybaert, Willem;Vandenhaute, Vincent;Regnault, Benjamin;De Ruyter, Vincent;Geboes, K.
Référence Clinical therapeutics, 43, 12, page (2136-2145.e2)
Publication Publié, 2021-12

Article révisé par les pairs

• Détails
• Contenu

Titre:	Efficacy and Safety of Lanreotide Autogel in the Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction: A Prospective Phase II Study
Auteur:	Duck, Lionel; Demolin, Gauthier; D'Hondt, Lionel; Dopchie, Catherine; Hendrickx, Koen; Lannoye, Beatrice; Bastin, Fabienne; Lossignol, Dominique; Hamdan, Ossama; Lybaert, Willem; Vandenhaute, Vincent; Regnault, Benjamin; De Ruyter, Vincent; Geboes, K.
Informations sur la publication:	Clinical therapeutics, 43, 12, page (2136-2145.e2)
Statut de publication:	Publié, 2021-12
Sujet CREF:	Pharmacologie
Mots-clés:	gastrointestinal
	intestinal obstruction
	intubation
	lanreotide
	palliative care
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:0149-2918
	info:doi/10.1016/j.clinthera.2021.10.014
	info:pii/S0149291821004525
	info:scp/85120172014